Hester Biosciences Ltd. | Small-cap | Healthcare
₹1,946.60
0.98%
| Hester Biosciences Stock Comparison:
Hester Biosciences vs Sun PharmaceuticalHester Biosciences vs Divi's LaboratoriesHester Biosciences vs Sun Pharma AdvancedHester Biosciences vs Aarti DrugsHester Biosciences vs Sequent ScientificHester Biosciences vs NIFTY 50 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 841.0M
Gross Profit 616.4M 73.29%
Operating Income 186.3M 22.15%
Net Income 173.0M 20.56%
EPS (Diluted) ₹20.33

Balance Sheet Metrics

Total Assets 6.5B
Total Liabilities 3.3B
Shareholders Equity 3.3B
Debt to Equity 1.00

Cash Flow Metrics

Revenue & Profitability Trend

Hester Biosciences Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i3.1B3.0B2.7B2.4B2.1B
Cost of Goods Sold i1.0B1.1B858.2M725.4M589.8M
Gross Profit i2.1B1.9B1.8B1.6B1.6B
Gross Margin % i67.0%63.8%67.7%69.1%72.5%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i350.7M305.1M316.6M244.4M206.9M
Other Operating Expenses i466.0M430.2M398.3M290.8M243.8M
Total Operating Expenses i816.8M735.3M714.9M535.2M450.8M
Operating Income i452.4M422.8M415.6M564.7M587.6M
Operating Margin % i14.5%13.9%15.6%24.0%27.4%
Non-Operating Items
Interest Income i20.4M19.1M21.7M19.0M12.9M
Interest Expense i83.4M91.2M51.5M25.8M60.6M
Other Non-Operating Income-----
Pre-tax Income i395.7M319.5M401.5M535.0M501.0M
Income Tax i107.4M107.9M121.2M140.2M154.0M
Effective Tax Rate % i27.2%33.8%30.2%26.2%30.7%
Net Income i288.3M211.7M280.4M394.8M347.0M
Net Margin % i9.3%7.0%10.5%16.8%16.2%
Key Metrics
EBITDA i652.0M575.5M663.2M745.2M734.8M
EPS (Basic) i₹32.31₹22.20₹31.30₹46.22₹40.47
EPS (Diluted) i₹32.31₹22.20₹31.30₹46.22₹40.47
Basic Shares Outstanding i85068658506865850686585068658506865
Diluted Shares Outstanding i85068658506865850686585068658506865

Income Statement Trend

Hester Biosciences Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i55.9M123.1M126.7M242.7M208.1M
Short-term Investments i9.6M6.9M11.3M9.5M2.9M
Accounts Receivable i731.8M786.4M796.3M552.8M492.1M
Inventory i703.8M755.8M848.1M753.8M622.2M
Other Current Assets184.7M204.6M260.2M950.0K10.4M
Total Current Assets i2.0B2.1B2.3B1.9B1.6B
Non-Current Assets
Property, Plant & Equipment i59.2M57.9M53.4M49.1M57.7M
Goodwill i66.6M39.3M29.4M20.4M8.5M
Intangible Assets i66.6M39.3M29.4M20.4M8.5M
Long-term Investments-----
Other Non-Current Assets25.7M10.0K-400.0K400.0K10.0K
Total Non-Current Assets i4.6B4.5B4.4B3.7B2.5B
Total Assets i6.5B6.6B6.7B5.6B4.1B
Liabilities
Current Liabilities
Accounts Payable i294.2M264.4M299.8M180.2M280.9M
Short-term Debt i744.1M572.7M836.8M583.5M219.9M
Current Portion of Long-term Debt-----
Other Current Liabilities32.3M32.1M32.2M34.0M26.4M
Total Current Liabilities i1.3B1.1B1.5B969.0M613.7M
Non-Current Liabilities
Long-term Debt i1.4B1.9B1.9B1.7B880.3M
Deferred Tax Liabilities i59.3M74.1M73.5M65.1M72.8M
Other Non-Current Liabilities532.2M536.7M240.0M-10.0K-10.0K
Total Non-Current Liabilities i2.0B2.5B2.3B2.0B1.1B
Total Liabilities i3.3B3.6B3.8B2.9B1.8B
Equity
Common Stock i85.1M85.1M85.1M85.1M85.1M
Retained Earnings i2.4B2.2B2.0B1.8B1.5B
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i3.3B3.0B2.9B2.7B2.4B
Key Metrics
Total Debt i2.1B2.4B2.7B2.3B1.1B
Working Capital i699.9M1.1B789.0M978.7M1.0B

Balance Sheet Composition

Hester Biosciences Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i395.7M319.5M401.5M535.0M501.0M
Depreciation & Amortization i-----
Stock-Based Compensation i-----
Working Capital Changes i63.5M63.1M-336.9M-294.0M-61.1M
Operating Cash Flow i554.9M493.6M19.7M164.0M477.3M
Investing Activities
Capital Expenditures i2.7M550.0K250.0K1.8M420.0K
Acquisitions i--0-208.2M0
Investment Purchases i-----
Investment Sales i----10.7M
Investing Cash Flow i7.6M550.0K250.0K-206.4M11.2M
Financing Activities
Share Repurchases i-----
Dividends Paid i-51.7M-68.0M-85.1M-85.1M-56.2M
Debt Issuance i0204.7M320.4M1.0B182.1M
Debt Repayment i-331.2M-229.7M-171.4M-180.4M-118.4M
Financing Cash Flow i-400.6M-108.0M544.1M1.1B-122.3M
Free Cash Flow i439.2M237.4M-541.7M-870.0M173.1M
Net Change in Cash i162.0M386.1M564.1M1.1B366.1M

Cash Flow Trend

Hester Biosciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 43.11
Price to Book 5.13
Price to Sales 5.13
PEG Ratio 0.33

Profitability Ratios

Profit Margin 11.92%
Operating Margin 24.24%
Return on Equity 8.41%
Return on Assets 4.21%

Financial Health

Current Ratio 1.56
Debt to Equity 68.46
Beta 0.12

Per Share Data

EPS (TTM) ₹43.93
Book Value per Share ₹369.41
Revenue per Share ₹361.34

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
hesterbio16.2B43.115.138.41%11.92%68.46
Sun Pharmaceutical 3.9T37.885.4515.08%19.29%3.26
Divi's Laboratories 1.6T70.7910.9314.64%23.89%0.03
Sun Pharma Advanced 45.5B-13.34-21.04157.88%-53.22%-1.24
Aarti Drugs 44.8B23.753.2812.28%7.80%44.92
Sequent Scientific 43.9B154.186.242.84%1.85%62.47

Financial data is updated regularly. All figures are in the company's reporting currency.